Catalyst Wire Dossier Catalyst Wire Dossier

TOBRAMYCIN OPHTHALMIC SOLUTION

tobramycin ophthalmic solution · Alembic Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TOBRAMYCIN OPHTHALMIC SOLUTION, covering 2019-04-19 to 2021-07-07. Get the full timeline:

Most recent: FDA Approved: TOBRAMYCIN OPHTHALMIC SOLUTION — Supplemental Application (Alembic Pharmaceuticals Inc.)

See pricing